Gerald R. (Jerry) Mattys joined Tactile Medical in January 2005 as Chief Executive Officer. From 2002 to 2004, Mr. Mattys was Chief Executive Officer of Medisyn Technologies, Inc., a development stage biotechnology company. From 2000 to 2002, Mr. Mattys served as President and Chief Executive Officer of Timm Medical Technologies, Inc. where under his leadership, Timm Medical completed three strategic alliances and was successfully sold to Endocare, Inc. Mr. Mattys also held a variety of division management positions with Mallinckrodt, Inc. and Nellcor Puritan Bennett, Inc., most recently as Vice President and General Manager of Mallinckrodt’s Alternate Care Business (a $300 million division). He currently serves on the board of Tactile Medical and the American Venous Forum Foundation. His past board service included the American College of Phlebology Foundation and Medical Alley.
Tactile Medical (Nasdaq: TCMD) is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions. Visit www.tactilemedical.com for more information.
